The global adult clinical oral nutrition market is expected to experience significant growth in the coming years, according to a new market research report. The report provides insights into the current state of the market, key players, and growth opportunities.
The adult clinical oral nutrition market is driven by the increasing prevalence of chronic diseases, such as diabetes, cancer, and cardiovascular diseases, which require specialized nutrition therapy. The market was valued at approximately USD 3.7 billion in 2020 and is expected to reach USD 6.4 billion by 2028, growing at a CAGR of 6.7% during the forecast period.
The report notes that the increasing awareness about the benefits of clinical nutrition therapy, coupled with the availability of innovative products, is also driving the growth of the market. Advances in technology and the development of personalized nutrition therapy are also contributing to the growth of the market.
One of the key trends in the market is the development of products that can be customized to meet the specific needs of patients. Companies are investing in research and development to develop innovative products that can address the unique nutritional needs of individuals. This trend is expected to continue, as more is understood about the role of nutrition in managing chronic diseases.
Another trend highlighted in the report is the use of emerging technologies in the development of clinical oral nutrition products. Companies are exploring the use of artificial intelligence and machine learning to develop personalized nutrition plans. This trend is expected to accelerate in the coming years, as more data becomes available to inform personalized nutrition plans.
Geographically, North America is the largest market for adult clinical oral nutrition products, followed by Europe and the Asia-Pacific region. The report predicts that the Asia-Pacific region will experience the highest growth rate during the forecast period, driven by the increasing healthcare expenditure and rising awareness about clinical nutrition products.
Key players in the market include Abbott Laboratories, Nestle Health Science, Danone S.A., Baxter International Inc., and Fresenius Kabi AG, among others. These companies are investing in research and development to develop innovative products and technologies that can meet the evolving needs of patients and healthcare professionals.
In conclusion, the global adult clinical oral nutrition market is poised for significant growth in the coming years, driven by innovative trends and emerging technologies. The development of personalized nutrition therapy, the use of emerging technologies, and increasing healthcare expenditure are all contributing to the growth of the market. This presents significant growth opportunities for industry stakeholders, healthcare professionals, and investors.
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Everest Market Insights journalist was involved in the writing and production of this article.